Global Plasma Expander Market Research Report 2022 - Market Size, Current Insights and Development Trends

Shock, syncope, and sudden death are manifestations of acute circulatory failure. Shock occurs primarily due to reduced blood volume (also called hypovolemia). The treatment of shock requires the blood volume to be restored as early as possible. There are different types of fluids used in the management of shock including whole blood plasma, plasma substitute or plasma expander, colloidal solution of dextran, colloidal solution of hydroxyethyl starch, and crystalline solution of sodium chloride and starch. Plasma expanders are agents that have high molecular weight and that boost the plasma volume by increasing the osmotic pressure. After administration, plasma expanders remain for an enough time to restore the volume of the circulatory fluid by increasing the osmotic pressure. There are two types of plasma expanders: colloidal and crystalloid. Crystalloid fluid is commonly used to expand the plasma volume. Crystalloid fluid is balanced salt solution that freely crosses the capillary walls and stays in the intravascular space for a shorter time compared to colloidal fluid. Also, the crystalloid fluids exhibit an early plasma expansion, which is of shorter life span. Crystalloid fluid is evenly distributed into the intracellular space. Moreover, it absorbs extracellular water into the intravascular space by creating osmotic pressure. However, absorption of excessive water by crystalloid fluid can cause pulmonary and peripheral edema.
The Plasma Expander market has witnessed a growth from USD XX million to USD XX million from 2017 to 2022. With a CAGR of X.X%, this market is estimated to reach USD XX million in 2029.

The report focuses on the Plasma Expander market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Plasma Expander market.

Major Players in the Plasma Expander market are:
BioTime
Grifols USA, LLC
Sanofi-aventis
Biogen Idec
Roche
Kedrion Biopharma Inc.
Astrazeneca
Novartis
CSL Behring
Pfizer Inc.
Bayer AG
Abbott
Shire US, Inc.
Abbott

On the basis of types, the Plasma Expander market is primarily split into:
Gelatine
Hydroxyethyl Starch
Other

On the basis of applications, the market covers:
Acute massive bleeding
Burns and scalds
Vomiting and Diarrhea
Others

Major Region

s or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others

Years considered for this report:

Historical Years:

2017-2021

Base Year:

2021

Estimated Year:

2022

Forecast Period:

2022-2029